US STOCKS
FUNDS
FOREX
SH/SZ-HK
HK STOCKS
 
 
 
 
 
All
|
China Industry News
|
China's Economy
|
China's Market Top News
|
Company News
News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
Content Sharing
Many PRC Firms Axe Drug Prices Again under '4+7' Volume-based Drug Procurement: Report
Some of the results of the extended "4+7" volume-based drug procurement coverage were unveiled in Shanghai this morning (24th), reported China Securities Journal.Presentl...
Reset
Send
The window will close in 5 seconds
Many PRC Firms Axe Drug Prices Again under '4+7' Volume-based Drug Procurement: Report
   Back  
2019/09/24 17:10
Share  
  
  
  
  
  
Print     
Font Size  
Some of the results of the extended "4+7" volume-based drug procurement coverage were unveiled in Shanghai this morning (24th), reported China Securities Journal.

Presently, bid-winners for Atorvastatin Calcium Tablets are Qilu Pharmaceutical, Cinmed Pharmaceuticals and Lepu Pharmaceuticals. Qilu offered the lowest price of RMB1.68 per box (10mg/14 tablets), implying an average price of RMB0.12 per tablet. The price declined by over 78% than the bid-winning price (RMB0.55 per tablet) under the "4+7" program last year.
~



AAStocks Financial News
Web Site: www.aastocks.com